Superconducting magnet
    71.
    发明授权
    Superconducting magnet 失效
    超导磁体

    公开(公告)号:US5424702A

    公开(公告)日:1995-06-13

    申请号:US335968

    申请日:1994-11-03

    摘要: A beam member which is installed at diametral portion in a ring shape superconducting coil container for supporting hoop stress of the coil, or a portion of radiant heat shield covering the beam member, is partly or entirely composed of electrical insulators or high resistivity materials. In accordance with the above composition, eddy current which is generated in the coil container when the superconducting coil container crosses magnetic field caused by eddy current which is generated in the radiant heat shield when the radiant heat shield crosses strong magnetic field caused by the superconducting coils with relative vibration of the radiant heat shield to the superconducting coil by a dynamic cause can be suppressed. Accordingly, heat generation in the superconducting coil container can be reduced, and consequently, generation of quenching can be prevented.

    摘要翻译: 安装在用于支撑线圈的环向应力的环形超导线圈容器的直径部分或覆盖梁构件的辐射热屏蔽的一部分的梁构件部分或全部由电绝缘体或高电阻率材料构成。 根据上述组成,当辐射热屏蔽穿过由超导线圈引起的强磁场时,当超导线圈容器穿过由辐射热屏蔽中产生的涡流引起的磁场时,在线圈容器中产生的涡流 可以抑制通过动态原因的辐射热屏蔽对超导线圈的相对振动。 因此,可以减少超导线圈容器中的发热,从而可以防止淬火的产生。

    Imidazonaphthyridine derivatives
    72.
    发明授权
    Imidazonaphthyridine derivatives 失效
    咪唑并萘啶衍生物

    公开(公告)号:US5364859A

    公开(公告)日:1994-11-15

    申请号:US999658

    申请日:1992-12-29

    CPC分类号: C07D471/14

    摘要: Disclosed are imidazonaphthyridine derivatives represented by formula (I) ##STR1## wherein: R.sup.1 represents lower alkyl or substituted or unsubstituted aryl; andX-Y-Z represents ##STR2## wherein R.sup.2 represents hydrogen, lower alkyl, alkenyl, aralkenyl, or --C (R.sup.5) H--(CH.sub.2).sub.n --R.sup.4 (wherein R.sup.4 represents substituted or unsubstituted aryl, substituted or unsubstituted pyridyl, substituted or unsubstituted furyl, hydroxy-substituted lower alkyl, lower alkanoyloxy, morpholino, lower alkanoyl, carboxy, lower alkoxycarbonyl, cycloalkyl, hydroxy, lower alkoxy, halogen or NR.sup.6 R.sup.7 wherein R.sup.6 and R.sup.7 independently represents hydrogen or lower alkyl; R.sup.5 represents hydrogen, lower alkyl, or phenyl; and n represents an integer of 0 to 3); and R.sup.3 represents hydrogen, mercapto, hydroxy, lower alkyl, or aryl and pharmaceutically acceptable sails thereof.The compounds show a potent anti-inflammatory, anti-allergic and broncho-dilative activity.

    摘要翻译: 公开了由式(I)表示的咪唑并吡啶衍生物其中:R1表示低级烷基或取代或未取代的芳基; 并且XYZ表示其中R2表示氢,低级烷基,烯基,芳烯基或-C(R5)H-(CH2)n-R4(其中R4表示取代或未取代的芳基,取代或未取代的吡啶基,取代或未取代的呋喃基 ,羟基取代的低级烷基,低级烷酰氧基,吗啉代,低级烷酰基,羧基,低级烷氧基羰基,环烷基,羟基,低级烷氧基,卤素或NR6R7,其中R6和R7独立地表示氢或低级烷基; R5代表氢,低级烷基或苯基 ; n表示0〜3的整数)。 并且R 3表示氢,巯基,羟基,低级烷基或芳基及其药学上可接受的风帆。 这些化合物显示有效的抗炎,抗过敏和支气管扩张活性。

    Coil structure and coil container
    73.
    发明授权
    Coil structure and coil container 失效
    线圈结构和线圈容器

    公开(公告)号:US5343180A

    公开(公告)日:1994-08-30

    申请号:US857251

    申请日:1992-03-25

    CPC分类号: H01F6/02 Y10S336/01

    摘要: There is disclosed a coil structure which can be rapidly energized or excited, and which reduces the generation of heat in a coil container by an eddy current due to a dynamic disturbance such as vibration and a magnetic field fluctuation, thereby suppressing the occurrence a quench. The coil container is constituted by a low-resistivity material, and a high-resistivity portion is provided at at least one portion of the coil container in the direction of the periphery of the coil container. The high-resistivity portion is provided at a position where a vibration displacement is small or a magnetic field fluctuation is small. When the coil structure is to be energized or excited, the eddy current produced in the direction of the periphery of the superconducting-coil container can be reduced at the high-resistivity portion, and when the dynamic disturbance develops, the generation of heat by the eddy current is suppressed by the low-resistivity material.

    摘要翻译: 公开了一种线圈结构,其可以被快速激励或激励,并且由于动态干扰(例如振动和磁场波动)而通过涡流减少线圈容器中的热量的产生,从而抑制骤冷的发生。 线圈容器由低电阻率材料构成,并且在线圈容器的至少一部分沿着线圈容器的周边方向设置高电阻部分。 高电阻部分设置在振动位移小或磁场波动小的位置。 当线圈结构被激励或激发时,可以在高电阻部分减小在超导线圈容器的周边方向产生的涡电流,并且当动态干扰发生时,由 涡流被低电阻率材料抑制。

    Method of chucking semiconductor wafers
    74.
    发明授权
    Method of chucking semiconductor wafers 失效
    夹紧半导体晶片的方法

    公开(公告)号:US5335457A

    公开(公告)日:1994-08-09

    申请号:US966484

    申请日:1992-10-26

    CPC分类号: H01L21/6838

    摘要: A method of chucking semiconductor wafers, in which a silicone elastic layer with high flatness is formed on the surface of a hard substrate having fine through-holes for vacuum chucking. Next fine through-holes in the silicone elastic layer, are provided, each through-hole communicating with the fine through-holes of the hard substrate. Next a semi-conductor wafer is held on the hard substrate by vacuum chucking from the back side of the substrate, so as to hold the semiconductor wafer securely on the substrate only by surface adhesion of the silicone elastic layer during polishing of the wafer. This method does not require wax or similar adhesive for holding the semiconductor wafer on the hard surface during the polishing process, and can realize a high-precision and high-quality surface polishing process for the semiconductor wafers.

    摘要翻译: 一种夹持半导体晶片的方法,其中在具有用于真空吸附的精细通孔的硬质基板的表面上形成具有高平坦度的硅氧烷弹性层。 在硅弹性层中的下一个细小的通孔中,每个通孔与硬质基底的细通孔相通。 接下来,半导体晶片通过从基板的背面真空夹持而保持在硬质基板上,以便仅在晶片抛光期间通过硅树脂弹性层的表面粘合将半导体晶片牢固地保持在基板上。 该方法不需要在抛光过程中将半导体晶片保持在硬表面上的蜡或类似的粘合剂,并且可以实现用于半导体晶片的高精度和高质量的表面抛光工艺。

    Halogeno-4-methylpyrazoles
    75.
    发明授权
    Halogeno-4-methylpyrazoles 失效
    卤代-4-甲基吡唑

    公开(公告)号:US5220028A

    公开(公告)日:1993-06-15

    申请号:US869046

    申请日:1992-04-14

    IPC分类号: C07D231/16 C07D401/04

    CPC分类号: C07D401/04 C07D231/16

    摘要: There are disclosed halogeno-4-methylpyrazoles represented by the formula (I): ##STR1## wherein R represents an alkyl group having 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group or a substituted or unsubstituted pyridyl group; X represents a hydrogen atom or a halogen atom; and Y represents a halogen atom, and a process for preparing the same which comprises reacting 1-substituted-4-methylpyrazoles of the formula (II): ##STR2## wherein R has the same meaning as defined above, with a halogen.

    摘要翻译: 公开了由式(I)表示的卤代-4-甲基吡唑:其中R表示碳原子数1〜4的烷基,取代或未取代的苯基或取代或未取代的吡啶基; X表示氢原子或卤原子; 和Y表示卤素原子,及其制备方法,其包括使式(II)的1-取代-4-甲基吡唑:其中R具有与上述定义相同的含义与卤素 。

    Hexitol derivatives
    78.
    发明授权
    Hexitol derivatives 失效
    HEXITOL衍生物

    公开(公告)号:US5120737A

    公开(公告)日:1992-06-09

    申请号:US764827

    申请日:1991-09-24

    IPC分类号: C07D493/04

    CPC分类号: C07D493/04

    摘要: A hexitol derivative represented by formula (I) ##STR1## wherein R represents hydrogen, unsubstituted or lower alkyl-substituted cycloalkyl, lower alkenyl, lower alkoxy, lower alkanoyl, piperidyl or ##STR2## wherein each of m and n independently represents an integer of 0 to 3; each of X, Y and Z independently represents hydrogen, lower alkyl, lower alkoxy, lower alkanoyl, lower alkanoyloxy, hydroxyl, halogen or nitro or a pharmaceutically acceptable salt thereof.

    Hexitol derivatives having vasodilative activity
    79.
    发明授权
    Hexitol derivatives having vasodilative activity 失效
    具有血液活性的HEXITOL衍生物

    公开(公告)号:US5053408A

    公开(公告)日:1991-10-01

    申请号:US508701

    申请日:1990-04-13

    CPC分类号: C07D493/04

    摘要: Disclosed is a hexitol derivative represented by the formula (I): ##STR1## wherein Q represents a formula selected from the group consisting of ##STR2## wherein a represents NH, O or S;each of b, c and d independently represents CH or N;each of R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represents hydrogen, lower alkyl, trifluoromethyl, aryl, lower alkanoyloxy, amino, lower alkylamino, lower alkanoylamino, lower alkanoyl, aroyl, halogen, nitro, (CH.sub.2).sub.m OR.sup. 7, (CH.sub.2).sub.m SR.sup.7, (CH.sub.2).sub.m CO.sub.2 R.sup.7 where R.sup.7 represents hydrogen or lower alkyl and m represents an integer of 0 to 3;each of R.sup.5 and R.sup.6 independently represents hydrogen or lower alkyl;U represents >N-- or ##STR3## W represents a single bond, --O-- or --S--; X represents ##STR4## wherein each of Y.sup.1 and Y.sup.2 independently represents hydrogen, lower alkyl, hydroxyl, lower alkanoyloxy, nitrile or phenyl; or Y.sup.1 and Y.sup.2 are combined together to form oxygen;each of Y.sup.3 and Y.sup.4 independently represents hydrogen or lower alkyl; and l is an integer of 0 to 6, and where l is an integer of 2 to 6, each ##STR5## may be the same or different; Z represents hydrogen or nitro; and, n is 2 or 3 or a pharmaceutically acceptable salt thereof. The compounds show prominent coronary vasodilative activities, and are useful in treating angina pectoris and myocardial infarction.